Nicotine Replacement Therapy (NRT) Market to Exhibit a CAGR of 4.8% from 2025 to 2032; British American Tobacco Secured the Health Canada Approval for Selling Zonnic Nicotine Pouches, Which Enhanced its Position

The global nicotine replacement therapy (NRT) market size was valued at USD 2.94 billion in 2024 and is projected to grow from USD 3.07 billion in 2025 to USD 4.27 billion by 2032, exhibiting a CAGR of 4.8% during the forecast period.

Fortune Business Insights™ presents this information in its report titled “Nicotine Replacement Therapy (NRT) Market Size, Share & Industry Analysis, By Type (Gums, Patches, Lozenges, Inhalers, and Others), By Distribution Channel (Hospital & Retail Pharmacies, Retail Stores, and Online Channels), and Regional Forecast, 2025-2032”.

Nicotine replacement therapy (NRT) is a treatment that includes the replacement of tobacco products with low nicotine doses. The growing number of tobacco users and smoking is one of the prominent factors causing disorders, such as respiratory diseases, cancer, cardiovascular diseases, and others, impelling the market expansion.

The market stifled slowly amid the COVID-19 pandemic owing to the upheavals in supply chain and demand, decline in sales of the product, and others. In addition, a drop in revenue was witnessed by some of the leading companies owing to the reduced demand for NRT products during the pandemic. Despite this, the market observed a surge in its growth in 2021. This can be credited to the growth in sales of the product, relaxation in regulations, and an increase in awareness regarding NRT products and their rise in demand, among others.

British American Tobacco Receives Health Canada Approval for Zonnic Nicotine Pouches as Smoking Cessation Aid

In July 2023, British American Tobacco obtained Health Canada approval to market Zonnic nicotine pouches as a nicotine replacement therapy smoking cessation product in accordance with the Natural Health Product Regulations.

Market Value to Grow Owing to Growing Government Initiatives to Promote NRT Adoption and Rising Awareness

The nicotine replacement therapy (NRT) market growth is driven by a rise in government initiatives for the promotion of NRT uptake and increasing awareness. In September 2022, the National List of Essential Medicines (NLEM), which included nicotine replacement therapy (NRT) was issued by the Indian government.

Despite such growth opportunities, the side effects related to NRT products, along with the presence of alternative products, may hamper market growth.

Prominent Companies Focus on Getting Product Approvals to Boost Their Position

Johnson & Johnson Services, Inc. is one of the prominent companies in the market, capturing the maximum share. This can be attributed to the availability of a wider product portfolio, a robust emphasis on strengthening its brand presence, and others. Several strategic initiatives are being adopted by top players to stand out from the competition. Many of these companies are opting for mergers & acquisitions, joint ventures, and others. Several players are also emphasizing receiving product approvals to enhance their position.

List of Key Players Profiled:

• Haleon Group of Companies (U.K.)
• Johnson & Johnson Services, Inc. (U.S.)
• Perrigo Company plc (Ireland)
• Pierre Fabre group (France)
• Pfizer, Inc. (U.S.)
• Cipla, Ltd. (India)
• Dr. Reddy’s Laboratories Ltd. (India)
• ITC Limited (India)

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/nicotine-replacement-therapy-nrt-market-103362

Key Industry Development

• May 2023: Final approval from the U.S. Food and Drug Administration (FDA) was secured by Perrigo Company plc’s nicotine-coated mint Lozenges, 2 mg and 4 mg over-the-counter (OTC). This approval boosted the offerings of the company.

Further Report Findings:

• North America market size was USD 1.37 billion in 2024 and is poised to register the largest nicotine replacement therapy (NRT) market share during the forecast period. This can be credited to the increasing uptake of NRT products among the population in the region.
• Europe captured the second dominant share in 2024, attributed to the massive supply of nicotine replacement products across smoking cessation hospitals and clinics for easy accessibility among the general population.
• By type, the market for nicotine replacement therapy (NRT) is segregated into patches, inhalers, gums, lozenges, and others. The gums segment occupied the largest share in 2024. Gums offer high potential benefits, including quick absorption and action, as compared to other therapies. This factor is bolstering the gums segment growth.

Table of Segmentation